{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:55Z","timestamp":1767135055068,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010028","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000}}],"reference-count":135,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010028.pub2","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T05:03:46Z","timestamp":1418792626000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes"],"prefix":"10.1002","volume":"2014","author":[{"given":"Charlotte","family":"Vrinten","sequence":"first","affiliation":[{"name":"VU University Medical Center; Community Genetics Section, Clinical Genetics; BS7, D450 PO Box 7057 Amsterdam Netherlands 1007 MB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeli M","family":"van der Zwaag","sequence":"additional","affiliation":[{"name":"VU University Medical Center; Community Genetics Section, Clinical Genetics; BS7, D450 PO Box 7057 Amsterdam Netherlands 1007 MB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S","family":"Weinreich","sequence":"additional","affiliation":[{"name":"VU University Medical Center; Community Genetics Section, Clinical Genetics; BS7, D450 PO Box 7057 Amsterdam Netherlands 1007 MB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob JPM","family":"Scholten","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care \/ University Medical Center Utrecht; Dutch Cochrane Centre; Room Str. 6.126 P.O. Box 85500 Utrecht Netherlands 3508 GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan JGM","family":"Verschuuren","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Neurology; PO Box 9600 Leiden Netherlands 2300 RC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1090-3798(08)70385-4","article-title":"Treatment of congenital myasthenia with ephedrine: a case report","volume":"11","author":"Edvardson","year":"2007","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0002|cit2","unstructured":"Abicht A Lochm\u00fcller H Congenital Myasthenic Syndromes GeneReviews at Gene Tests: Medical Genetics Information Resource (database online) Seattle University of Washington. Available at www.ncbi.nlm.nih.gov\/books\/NBK1168\/"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0003|cit3","first-page":"757","article-title":"Congenital myasthenia as a cause of respiratory failure in two infants and a toddler: case reports","volume":"75","author":"Adamovi\u010dov\u00e1","year":"2012","journal-title":"Ceska a Slovenska Neurologie a Neurochirurgie"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mus.20944","article-title":"Variable phenotypes associated with mutations in DOK7","volume":"37","author":"Anderson","year":"2008","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nmd.2003.11.004","article-title":"Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine","volume":"14","author":"Banwell","year":"2004","journal-title":"Neuromuscular Disorders"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpn.2011.03.006","article-title":"Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes","volume":"15","author":"Bari\u0161i\u0107","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"issue":"9-10","key":"10.1002\/14651858.CD010028.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nmd.2011.06.1045","article-title":"Pregnancy outcome in congenital myasthenic syndromes","volume":"21","author":"Bauduin","year":"2011","journal-title":"Neuromuscular Disorders"},{"issue":"7","key":"10.1002\/14651858.CD010028.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.nmd.2005.05.001","article-title":"126th International workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, The Netherlands","volume":"15","author":"Beeson","year":"2005","journal-title":"Neuromuscular Disorders"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-009-5405-y","article-title":"Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7","volume":"257","author":"Ben Ammar","year":"2010","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010028.pub2-BIB0011|cit11","first-page":"455","volume":"21","author":"Bestu\u00e9","year":"2006","journal-title":"Comunicacones Orales de la Sociedad Espa\u00f1ola de Neurolog\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archinte.1934.00160070044003","article-title":"Myasthenia gravis: the effect of treatment with glycine and ephedrine; third report","volume":"53","author":"Boothby","year":"1934","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0013|cit13","first-page":"S129","article-title":"Ephedrine treatment of seven patients with congenital endplate (EP) acetylcholinesterase (AChE) deficiency","volume":"16","author":"Brengman","year":"2006","journal-title":"Neuromuscular Disorders"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nmd.2004.03.005","article-title":"Distinct phenotypes of congenital acetylcholine receptor deficiency","volume":"14","author":"Burke","year":"2004","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jnnp.2009.181966","article-title":"A treatable muscle disease","volume":"9","author":"Burke","year":"2009","journal-title":"Practical Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1090-3798(11)70073-3","article-title":"Salbutamol treatment in children with DOK7 congenital myasthenic syndrome","volume":"15","author":"Burke","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2012.11.004","article-title":"Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations","volume":"23","author":"Burke","year":"2013","journal-title":"Neuromuscular disorders"},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008111.pub2","article-title":"Thymectomy for non-thymomatous myasthenia gravis","author":"Cea","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1469-8749.1984.tb08163.x","article-title":"Myasthenia gravis in Chinese children","volume":"26","author":"Chan-Lui","year":"1984","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nmd.2011.12.004","article-title":"186th ENMC international workshop: congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands","volume":"22","author":"Chaouch","year":"2012","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijoa.2010.08.007","article-title":"Maternal myasthenia gravis complicated by fetal arthrogryposis multiplex congenita","volume":"20","author":"Chieza","year":"2011","journal-title":"International Journal of Obstetric Anesthesia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0022|cit22","first-page":"24","article-title":"Variable response to ephedrine in COLQ congenital myasthenic syndrome despite phenotypic and genotypic homogeneity within the same family","volume":"51","author":"Chillingworth","year":"2009","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0960-8966(10)70066-3","article-title":"Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms","volume":"20","author":"Cossins","year":"2010","journal-title":"Neuromuscular Disorders"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2125.2005.02254.x","article-title":"Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects","volume":"59","author":"Csajka","year":"2005","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0025|cit25","first-page":"269","article-title":"Pupillary dysfunction in myasthenia gravis: possible involvement of ciliary ganglion","volume":"21","author":"Dalkara","year":"1988","journal-title":"Hacettepe Medical Journal"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0026|cit26","unstructured":"Drug Enforcement Administration U.S. Department of Justice Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine Federal Register. Document number: 2010-1968."},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0027|cit27","first-page":"797","article-title":"Congenital myasthenic syndromes","volume":"30","author":"Della Marina","year":"2011","journal-title":"Nervenheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0301-2115(02)00051-9","article-title":"Myasthenia gravis in pregnancy: report on 69 cases","volume":"104","author":"Djelmis","year":"2002","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"25","key":"10.1002\/14651858.CD010028.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13760-013-0179-5","article-title":"Severe scoliosis in a patient with COLQ mutation and congenital myasthenic syndrome: a clue for diagnosis","volume":"113","author":"Duran","year":"2013","journal-title":"Acta Neurologica Belgica"},{"issue":"15","key":"10.1002\/14651858.CD010028.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.1930.27120410003009c","article-title":"A report of progress on the use of ephedrine in a case of myasthenia gravis","volume":"94","author":"Edgeworth","year":"1930","journal-title":"Journal of the American Medical Association"},{"issue":"18","key":"10.1002\/14651858.CD010028.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.1933.27420180001007","article-title":"The effect of ephedrine in the treatment of myasthenia gravis: second report","volume":"100","author":"Edgeworth","year":"1933","journal-title":"Journal of the American Medical Association"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1090-3798(08)70385-4","article-title":"Treatment of congenital myasthenia with ephedrine: a case report","volume":"11","author":"Edvardson","year":"2007","journal-title":"European Journal of Paediatric Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0034|cit34","first-page":"101","article-title":"Myasthenia with positive anti-MuSK-positive antibodies in a young man: a case report","volume":"71","author":"Ehler","year":"2008","journal-title":"Ceska a Slovenska Neurologie a Neurochirurgie"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0035|cit35","unstructured":"European Medicines Agency European Public Assessment Report database Available from: www.ema.europa.eu"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mus.10269","article-title":"Congenital myasthenic syndromes: progress over the past decade","volume":"27","author":"Engel","year":"2003","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1405.039","article-title":"Further observations in congenital myasthenic syndromes","volume":"1132","author":"Engel","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11910-011-0234-7","article-title":"Congenital myasthenic syndromes in 2012","volume":"12","author":"Engel","year":"2012","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0041|cit41","unstructured":"Effective Practice Organisation of Care (EPOC) EPOC Resources for review authors Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: epocoslo.cochrane.org\/epoc-specific-resources-review-authors"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Ernst ME Hartz A Phenylpropanolamine and hemorrhagic stroke New England Journal of Medicine 2001 1094 5","DOI":"10.1056\/NEJM200104053441411"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Current Opinion in Neurology"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0044|cit44","unstructured":"Eymard B Congenital myasthenic syndromes www.orpha.net"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010028.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0035-3787(13)70060-2","article-title":"Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy. The French National Congenital Myasthenic Syndrome Network experience.","volume":"169","author":"Eymard","year":"2013","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0046|cit46","unstructured":"Felice K Relva G Ephedrine in the treatment of congenital myasthenic syndrome Muscle & Nerve 1996 799 800"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002275","article-title":"Plasma exchange for generalised myasthenia gravis","author":"Gajdos","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010028.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002277.pub4","article-title":"Intravenous immunoglobulin for myasthenia gravis","author":"Gajdos","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0028-3908(79)90017-0","article-title":"Ephedrine and neuromuscular transmission, in vivo","volume":"18","author":"Gallagher","year":"1979","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2012.02.003","article-title":"Recurrent COLQ mutation in congenital myasthenic syndrome","volume":"46","author":"Guven","year":"2012","journal-title":"Pediatric Neurology"},{"issue":"25","key":"10.1002\/14651858.CD010028.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/WCO.0b013e328364dc0f","article-title":"Congenital myasthenic syndromes: an update","volume":"26","author":"Hantai","year":"2013","journal-title":"Current Opinion in Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clineuro.2012.06.038","article-title":"Can a rare form of myasthenia gravis shed additional light on disease mechanisms?","volume":"115","author":"Haran","year":"2013","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005224.pub2","article-title":"Immunosuppressive agents for myasthenia gravis","author":"Hart","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0055|cit55","first-page":"521","article-title":"A case report of myasthenia gravis associated with Hashimoto's thyroiditis","volume":"35","author":"Hashimoto","year":"1981","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0056|cit56","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0057|cit57","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huz\u00e9","year":"2009","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/096470490512580","article-title":"Special section on myasthenia: the contributions of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London","volume":"14","author":"Johnston","year":"2005","journal-title":"Journal of the History of the Neurosciences: Basic and Clinical Perspectives"},{"issue":"Nov","key":"10.1002\/14651858.CD010028.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-2-44","article-title":"Myasthenia gravis","volume":"2","author":"Juel","year":"2007","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle & Nerve"},{"issue":"25","key":"10.1002\/14651858.CD010028.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/1817-1745.92832","article-title":"Bulbar dysfunction: An early presentation of congenital myasthenic syndrome in three infants","volume":"6","author":"Khan","year":"2011","journal-title":"Journal of Pediatric Neurosciences"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","article-title":"Congenital myasthenic syndromes in childhood: diagnostic and management challenges","volume":"201-202","author":"Kinali","year":"2008","journal-title":"Journal of Neuroimmunology"},{"issue":"8","key":"10.1002\/14651858.CD010028.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00115-010-2995-7","article-title":"Course and treatment of myasthenia gravis during pregnancy","volume":"81","author":"Klehmet","year":"2010","journal-title":"Nervenarzt"},{"issue":"11","key":"10.1002\/14651858.CD010028.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2013.06.002","article-title":"DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children","volume":"23","author":"Klein","year":"2013","journal-title":"Neuromuscular Disorders"},{"issue":"11","key":"10.1002\/14651858.CD010028.pub2-BIB0069|cit69","first-page":"24","article-title":"Ephedrine treatment results in profound functional improvements in DOK-7 congenital myasthenia","volume":"80","author":"Lashley","year":"2009","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD010028.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010028.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgGI antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and DOK-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle & Nerve"},{"issue":"9","key":"10.1002\/14651858.CD010028.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.nmd.2011.06.1043","article-title":"Challenges in diagnosis and management of a patient with severe congenital myasthenic syndrome mutated in CHRNE","volume":"21","author":"Linzoain","year":"2011","journal-title":"Neuromuscular Disorders"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0074|cit74","article-title":"Chapter 14: Adverse effects","volume-title":"Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Loke","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.12.001","article-title":"Congenital myasthenic syndrome: a brief review","volume":"46","author":"Lorenzoni","year":"2012","journal-title":"Pediatric Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mus.23724","article-title":"Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation","volume":"48","author":"Lorenzoni","year":"2013","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/bja\/56.6.651","article-title":"Myasthenia gravis and atracurium: a case report","volume":"56","author":"Macdonald","year":"1984","journal-title":"British Journal of Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.57.2.279","article-title":"Presynaptic congenital myasthenic syndrome due to quantal release deficiency","volume":"57","author":"Maselli","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"12","key":"10.1002\/14651858.CD010028.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction","volume":"19","author":"Maselli","year":"2010","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-0004.2010.01602.x","article-title":"Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE","volume":"80","author":"Maselli","year":"2011","journal-title":"Clinical Genetics"},{"issue":"756","key":"10.1002\/14651858.CD010028.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/pgmj.64.756.787","article-title":"Myasthenia gravis and Schmidt syndrome","volume":"64","author":"McAlpine","year":"1988","journal-title":"Postgraduate Medical Journal"},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006986.pub3","article-title":"Acetylcholinesterase inhibitor treatment for myasthenia gravis","author":"Mehndiratta","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","article-title":"Chapter 33: Geoepidemiology of myasthenia gravis","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmunity Reviews"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0085|cit85","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) Pseudoephedrine- and ephedrine-containing medicines: 2012 review of actions to manage the risk of misuse Available from www.mhra.gov.uk"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010028.pub2-BIB0086|cit86","first-page":"185","article-title":"Phenotypical spectrum of congenital myasthenic syndrome caused by mutations in COLQ gene","volume":"255","author":"Mihaylova","year":"2008","journal-title":"Journal of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD010028.pub2-BIB0087|cit87","first-page":"A426","article-title":"Clinical and molecular genetic findings in 22 COLQ-mutant CMS patients","volume":"70","author":"Mihaylova","year":"2008","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1002\/14651858.CD010028.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"issue":"22","key":"10.1002\/14651858.CD010028.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181c3fce9","article-title":"Refinement of the clinical phenotype in MUSK-related congenital myasthenic syndromes","volume":"73","author":"Mihaylova","year":"2009","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD010028.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-8993(96)00894-3","article-title":"Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine and albuterol","volume":"740","author":"Milone","year":"1996","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0091|cit91","unstructured":"NCT00294658 A multi-center, single-blind, randomized study comparing thymectomy to no thymectomy in non-thymomatous myasthenia gravis (MG) patients receiving prednisone clinicaltrials.gov\/show\/NCT00294658"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3476(35)80117-0","article-title":"Myasthenia gravis in a child: observations on the effect of ephedrine therapy","volume":"7","author":"Nelson","year":"1935","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD010028.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/brain\/awu160","article-title":"Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy","volume":"137","author":"Nicole","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2008.05.001","article-title":"Congenital myasthenic syndromes","volume":"16","author":"Nogajski","year":"2009","journal-title":"Journal of Clinical Neuroscience"},{"issue":"Pt 6","key":"10.1002\/14651858.CD010028.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2008.05.030","article-title":"The congenital myasthenic syndromes","volume":"201-202","author":"Palace","year":"2008","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nmd.2011.08.002","article-title":"Clinical features in a series of fast channel congenital myasthenia syndrome","volume":"22","author":"Palace","year":"2012","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/088307389200700202","article-title":"Transient neonatal myasthenia gravis","volume":"7","author":"Papazian","year":"1992","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.35.3.385","article-title":"Multiple sclerosis associated with defects in neuromuscular transmission","volume":"35","author":"Patten","year":"1972","journal-title":"Journal of Neurology, Neurosurgery, & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000084268","article-title":"Mary Broadfoot Walker (1888-1974): a historic discovery in myasthenia gravis","volume":"53","author":"Pearce","year":"2005","journal-title":"European Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00003081-199103000-00012","article-title":"Myasthenia gravis in mothers and their newborns","volume":"34","author":"Plauch\u00e9","year":"1991","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0103|cit103","article-title":"Chapter 13: Including non-randomized studies","volume-title":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]","author":"Reeves","year":"2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0104|cit104","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"12","key":"10.1002\/14651858.CD010028.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.nmd.2010.08.002","article-title":"Respiratory management of congenital myasthenic syndromes in childhood: Workshop 8th December 2009, UCL Institute of Neurology, London, UK","volume":"20","author":"Robb","year":"2010","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effects of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"Sadeh","year":"2011","journal-title":"Muscle & Nerve"},{"issue":"12","key":"10.1002\/14651858.CD010028.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00415-010-5745-7","article-title":"Neuromuscular disorders and 2010: recent advances","volume":"257","author":"Sarkozy","year":"2010","journal-title":"Journal of Neurology"},{"issue":"9-10","key":"10.1002\/14651858.CD010028.pub2-BIB0108|cit108","first-page":"818","article-title":"Therapeutic effects of ephedrine in congenital myasthenic syndrome due to DOK7 mutations","volume":"17","author":"Schara","year":"2007","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","article-title":"Therapeutic strategies in congenital myasthenic syndromes","volume":"5","author":"Schara","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1002\/14651858.CD010028.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nmd.2009.09.008","article-title":"Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations","volume":"19","author":"Schara","year":"2009","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0032-1323850","article-title":"Congenital myasthenic syndromes: current diagnostic and therapeutic approaches","volume":"43","author":"Schara","year":"2012","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1002\/14651858.CD010028.pub2-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002828.pub2","article-title":"Corticosteroids for myasthenia gravis","author":"Schneider-Gold","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010028.pub2-BIB0113|cit113","first-page":"346","article-title":"Urecholine in myasthenia gravis","volume":"72","author":"Schwarz","year":"1955","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen","year":"2008","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0028-3908(79)90018-2","article-title":"Ephedrine: a postsynaptic depressant drug at the mammalian neuromuscular junction","volume":"18","author":"Shinnick-Gallagher","year":"1979","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010028.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90025-I","article-title":"Ephedrine: effects on neuromuscular transmission","volume":"623","author":"Sieb","year":"1993","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0117|cit117","first-page":"1","article-title":"Myasthenia gravis: an analysis of 295 cases","volume":"42 Suppl 23","author":"Simpson","year":"1966","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD010028.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awl200","article-title":"Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'","volume":"129","author":"Slater","year":"2006","journal-title":"Brain"},{"issue":"7","key":"10.1002\/14651858.CD010028.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2010.05.007","article-title":"DOK7 mutations presenting as a proximal myopathy in French Canadians","volume":"20","author":"Srour","year":"2010","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1213\/ane.0b013e3181823d11","article-title":"Obstetric and anesthetic management of severe congenital myasthenia syndrome","volume":"107","author":"Terblanche","year":"2008","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0121|cit121","unstructured":"United Nations Office on Drugs and Crime United Nations convention against illicit traffic in narcotic drugs and psychotropic substances, 1988 Available from www.unodc.org"},{"issue":"7","key":"10.1002\/14651858.CD010028.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.1939.02800320011003","article-title":"The diagnosis and treatment of myasthenia gravis: with special reference to the use of prostigmine","volume":"113","author":"Viets","year":"1939","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","article-title":"Antibodies in myasthenia gravis and related disorders","volume":"998","author":"Vincent","year":"2003 Sep","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5779","key":"10.1002\/14651858.CD010028.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"223","author":"Walker","year":"1934","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0125|cit125","volume-title":"A contribution to the study of myasthenia gravis [MD thesis]","author":"Walker","year":"1935"},{"issue":"9","key":"10.1002\/14651858.CD010028.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nmd.2011.06.1046","article-title":"P5.17 Congenital Myasthenic Syndromes with COLQ mutations: long term follow-up","volume":"21","author":"Wargon","year":"2011","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nmd.2011.09.002","article-title":"Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations","volume":"22","author":"Wargon","year":"2012","journal-title":"Neuromuscular Disorders"},{"issue":"6292","key":"10.1002\/14651858.CD010028.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(00)58566-3","article-title":"Prostigmin and ephedrine in myasthenia gravis","volume":"243","author":"Wilson","year":"1944","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010028.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00415-003-1063-7","article-title":"The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in th northern part of the province of South Holland","volume":"250","author":"Wirtz","year":"2003","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamaneurol.2013.5590","article-title":"Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome","volume":"71","author":"Witting","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD010028.pub2-BIB0131|cit131","unstructured":"Electronic Medicines Compendium Summary of product characteristics ephedrine hydrochloride 15, 30 & 60 mg tablets (Wockhardt UK Ltd) Electronic Medicines Compendium. Datapharm Communications Ltd"},{"issue":"3","key":"10.1002\/14651858.CD010028.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3476(44)80157-3","article-title":"Myasthenia gravis - its occurrence in a seven-year-old female child","volume":"25","author":"Yahr","year":"1944","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD010028.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/j.1469-8749.2010.03663.x","article-title":"Intra-familial variation in clinical manifestations and response to ephedrine in siblings with congenital myasthenic syndrome caused by novel COLQ mutations","volume":"52","author":"Yeung","year":"2010","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010028.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD010028.pub2-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010028","article-title":"Ephedrine for myasthenia gravis","author":"Vrinten","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010028.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T18:57:08Z","timestamp":1717613828000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010028.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":135,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010028.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}